Biocryst Pharmaceuticals buy Evercore ISI
Start price
13.01.25
/
50%
€7.73
Target price
13.01.26
€11.76
Performance (%)
-15.14%
Price
29.12.25
€6.56
Summary
This prediction is currently active. The prediction for Biocryst Pharmaceuticals disappoints with a performance of -15.14%. This prediction currently runs until 13.01.26. The prediction end date can be changed by Evercore_ISI at any time. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 2.726% | 2.726% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Evercore ISI from $10.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€9.11
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24
